2017 SOT | Drug Development and SEND | Evolving Current Practices Toward Future Opportunities

//2017 SOT | Drug Development and SEND | Evolving Current Practices Toward Future Opportunities

2017 SOT | Drug Development and SEND | Evolving Current Practices Toward Future Opportunities

By | 2017-04-05T09:56:51+00:00 April 3rd, 2017|Video|Comments Off on 2017 SOT | Drug Development and SEND | Evolving Current Practices Toward Future Opportunities

About the Author:

MPI Research, with global headquarters in Mattawan, Mich., provides safety evaluation, discovery, bioanalytical and analytical services to the biopharmaceutical, medical device, animal health, and chemical industries. The company offers comprehensive imaging solutions including preclinical imaging, radiochemistry, and data analysis. Scientific knowledge and experience, responsiveness, integrity, trust, teamwork, and dedication to strong and enduring Sponsor relationships are the defining attributes that characterize MPI Research as a high-performance, high-quality organization that is committed to bringing safer and more effective products to the world.